Terms: = Liver cancer AND PDCD1, CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1 AND Staging
8 results:
1. A Case of Curative Treatment with Apatinib and Camrelizumab Following liver Resection for Advanced Hepatocellular Carcinoma.
Huang J; Liang R; Lu C; Lu L; Li S; Tang M; Huang X; Huang S; Mai R; Gao X; Li S; Zeng C; Lin Y; Ye J
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686291
[TBL] [Abstract] [Full Text] [Related]
2. Nomogram Based on liver Function Test Indicators for Survival Prediction in Nasopharyngeal Carcinoma Patients Receiving pd-1 Inhibitor Therapy.
Liang L; Li Y; Hong Y; Ji T; Chen H; Lin Z
Curr Oncol; 2023 Jul; 30(8):7189-7202. PubMed ID: 37623002
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and safety of Lenvatinib-based combination therapies for patients with unresectable hepatocellular carcinoma: a single center retrospective study.
Huang J; Wang ZG; Tao QF; Yang Y; Yuan SX; Gu FM; Liu H; Pan ZY; Jiang BG; Lau WY; Zhou WP
Front Immunol; 2023; 14():1198562. PubMed ID: 37483609
[TBL] [Abstract] [Full Text] [Related]
4. pd-1 expression in hepatocellular carcinoma predicts liver-directed therapy response and bridge-to-transplant survival.
Núñez KG; Sandow T; Fort D; Hibino M; Wright P; Cohen AJ; Thevenot PT
Cancer Immunol Immunother; 2022 Jun; 71(6):1453-1465. PubMed ID: 34689234
[TBL] [Abstract] [Full Text] [Related]
5. Integrating Machine Learning and Tumor Immune Signature to Predict Oncologic Outcomes in Resected Biliary Tract cancer.
Ji GW; Wang K; Xia YX; Wang JS; Wang XH; Li XC
Ann Surg Oncol; 2021 Jul; 28(7):4018-4029. PubMed ID: 33230745
[TBL] [Abstract] [Full Text] [Related]
6. Patterns of distant metastases in 215 Merkel cell carcinoma patients: Implications for prognosis and surveillance.
Lewis CW; Qazi J; Hippe DS; Lachance K; Thomas H; Cook MM; Juhlin I; Singh N; Thuesmunn Z; Takagishi SR; McEvoy A; Doolittle-Amieva C; Bhatia S; Paulson KG; O'Malley RB; Wang CL; Nghiem P
Cancer Med; 2020 Feb; 9(4):1374-1382. PubMed ID: 31883234
[TBL] [Abstract] [Full Text] [Related]
7. Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma.
Tian MX; Liu WR; Wang H; Zhou YF; Jin L; Jiang XF; Tao CY; Tang Z; Zhou PY; Fang Y; Qu WF; Ding ZB; Peng YF; Dai Z; Qiu SJ; Zhou J; Lau WY; Fan J; Shi YH
BMC Med; 2019 Jun; 17(1):106. PubMed ID: 31164128
[TBL] [Abstract] [Full Text] [Related]
8. Upregulation of circulating PD-L1/pd-1 is associated with poor post-cryoablation prognosis in patients with HBV-related hepatocellular carcinoma.
Zeng Z; Shi F; Zhou L; Zhang MN; Chen Y; Chang XJ; Lu YY; Bai WL; Qu JH; Wang CP; Wang H; Lou M; Wang FS; Lv JY; Yang YP
PLoS One; 2011; 6(9):e23621. PubMed ID: 21912640
[TBL] [Abstract] [Full Text] [Related]